HIV-1 viral load assays for resource-limited settings

PLoS Medicine

Volumn 3, Issue 10, 2006, Pages 1743-1750

  Fiscus, Susan A ^a   Cheng, Ben ^b   Crowe, Suzanne M ^c   Demeter, Lisa ^d   Jennings, Cheryl ^e   Miller, Veronica ^b   Respess, Richard ^f   Stevens, Wendy ^g   Balakrishnan, Pachamuthu ^h   Branson, Bernie ^f   Burgess, Deborah ⁱ   Cabruja, Isabel ^j   Clayden, Polly ^k   Condliffe, Kate ^l   Corrigan, Gary ^m   De Baar, Michel ⁿ   Downing, Robert ^f   Ekong, Ernest ^o   Fox, Larry ^p   Gonsalves, Gregg ^q   Guarinieri, Mauro ^r   Guillerm, Martine ^s   Hellmann, Nick ^j   Kaplan, Jon ^f   Lee, Helen ^t   Lloyd, Robert ^u   Major, Carol ^v   Margherio, Lynn ^l   Martinez Picardo, Javier ^w   Newman, Daniel ^f   Peter, Trevor ^x   Rayfield, Mark ^f   Ridzon, Renee ^j   De Wit, Tobias Rinke ^y   Safrit, Jeff ^z   Spacek, Lisa ^aa   Spira, Tom ^f   Tamura, Kenji ^ab   Ussery, Michael ^ac   Valentine, Fred ^ad   Varnier, Oliviero ^ae   Ziermann, Rainer ^af   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Forum for Collaborative HIV Research   (United States)

^c MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h YRG CARE   (India)

ⁱ BILL AND MELINDA GATES FOUNDATION   (United States)

^j PerkinElmer Finland Oy   (Finland)

^k c o HIV i Base   (United Kingdom)

^l Clinton Foundation HIV/AIDS Initiative   (United States)

^m Cavidi Tech   (Sweden)

ⁿ Primagen   (Netherlands)

^o Nigeria HIV/AIDS Research Network   (Nigeria)

^p LabNow Inc   (United States)

^q Gay Men's Health Crisis   (United States)

^r EUROPEAN AIDS TREATMENT GROUP   (Belgium)

^s MÉDECINS SANS FRONTIÈRES   (Switzerland)

^t UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^u Research Think Tank Inc   (United States)

^v ONTARIO HIV TREATMENT NETWORK   (Canada)

^w UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^x Clinton Foundation   (Botswana)

^y PharmAccess   (Netherlands)

^z ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^aa JOHNS HOPKINS UNIVERSITY   (United States)

^ab WORLD HEALTH ORGANIZATION   (Switzerland)

^ac NATIONAL INSTITUTES OF HEALTH   (United States)

^ad NEW YORK UNIVERSITY   (United States)

^ae UNIVERSITY OF GENOA   (Italy)

^af BAYER CORPORATION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; RNA DIRECTED DNA POLYMERASE; ANTIRETROVIRUS AGENT; GAG PROTEIN; VIRUS RNA;

ANALYTIC METHOD; ARTICLE; ASSAY; DEVELOPED COUNTRY; ENZYME ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR BIOLOGY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RURAL AREA; VIRUS LOAD; ANALYTICAL EQUIPMENT; BLOOD; DEVELOPING COUNTRY; DISEASE TRANSMISSION; ECONOMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; IMMUNOLOGY; LABORATORY DIAGNOSIS; METHODOLOGY; NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIROLOGY;

ANTI-RETROVIRAL AGENTS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; POLYMERASE CHAIN REACTION; PREGNANCY; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33750851598     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030417     Document Type: Article

References (92)

1. Schuurman R, Descamps D, Weverling GJ, Kaye S, Tijnagel J, et al. (1996) Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 34: 3016-3022.
2. Holguin A, de Mendoza C, Soriano V (1999) Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes. Eur J Clin Microbiol Infect Dis 18: 256-259.
3. Nolte FS, Boysza J, Thurmond C, Clark WS, Lennox JL (1998) Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 36: 716-720.
4. Nkengasong JN, Kalou M, Maurice C, Bile C, Borget MY, et al. (1998) Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Cote d'Ivoire. J Clin Microbiol 36: 2495-2498.
5. Dyer JR, Pilcher CD, Shepard R, Schock J, Eron JJ, et al. (1999) Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 37: 447-449.
6. Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, et al. (2000) Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol 38: 1113-1120.
7. Murphy DG, Cote L, Fauvel M, Rene P, Vincelette J (2000) Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 38: 4034-4041.
8. Elbeik T, Delassandro R, Chen Y-MA, Soutchkov SV, Loftus RA, et al. (2003) Global cost modeling analysis of HIV-1 and HCV viral load assays. Expert Rev Pharmacoeconomics Outcomes Res 3: 383-407.
9. Crowe S, Turnball S, Oelrichs R, Dunne A (2003) Monitoring of HIV infection in resource-constrained countries. Clin Infect Dis 37 (Suppl 1): S25-S35.
10. Majchrowicz M (2003) Beyond antiretroviral access: Low-cost laboratory tests needed for the developing world. AIDS 17 (Suppl 4): S12-S15.
11. Balakrishnan P, Solomon S, Kumarasamy N, Mayer KH (2005) Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries. Indian J Med Res 121: 245-355.
12. Giacomini M, McDermott JL, Giri AA, Martini I, Lillo FV, et al. (1998) A novel and improved quantitative kinetic software for virologic colorimetric assays. J Virol Methods 73: 201-209.
13. Schupbach J, Boni J (1993) Quantitative and sensitive detection of immune-complex-dissociated HIV p24 antigen after boiling. J Virol Methods 43: 247-256.
14. Schupbach J, Boni J, Tomasik Z, Jendis J, Seger R, et al. (1994) Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group. J Infect Dis 170: 318-324.
15. Schupbach J, Flepp M, Pontelli D, Tomasik Z, Luthy R, et al. (1996) Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 10: 1085-1090.
16. Boni J, Opravil M, Tomasik Z, Rothen M, Bisset L, et al. (1997) Simple monitoring of antiretroviral therapy with a signal amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS 11: F47-F52.
17. Ledergerber B, Flepp M, Boni J, Tomosik Z, Come RW, et al. (2000) HIV-1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: Comparison with vira RNA measurement. J Infect Dis 181: 1280-1288.
18. Burgisser P, Vernazza P, Flepp M, Boni J, Tomasik Z, et al. (2000) Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 23: 138-144.
19. Schupbach J, Boni J, Flepp M, Tomasik Z, Joller H, et al. (2001) Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: An inexpensive alternative to tests for viral RNA. J Med Virol 65: 225-232.
20. Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JA, et al. (2002) Heat-denatured HIV-1 protein p24 antigen: Prognostic value in adults with early stage disease. J Infect Dis 186: 1181-1185.
21. Schupbach J, Boni J, Bisset LR, Tomasik Z, Fischer M, et al. (2003) HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. J Acquir Immune Defic Syndr 33: 292-299.
22. Schupbach J, Gunthard H, Joos B, Fischer M, Boni J, et al. (2005) HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4+ T cell loss. J Acquir Immune Defic Syndr 40: 250-256.
23. Pascual A, Cachafeiro A, Funk ML, Fiscus SA (2002) Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor HIV RNA assay. J Clin Microbiol 40: 2472-2475.
24. Lombart JP, Vray M, Kafando A, Léeme V, Ouedraogo-Taroe R, et al. (2005) Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 antigen assay for HIV load in Burkino Faso, West Africa. AIDS 19: 1273-1977.
25. Stevens G, Rekhviashvili N, Scott LE, Gonin R, Stevens W (2005) Evaluation of two commercially available, inexpensive alternative HIV-1 viral load assays for assessing viral load in a cohort of HIV-1 infected subtype C patients from South Africa. J Clin Microbiol 43: 857-861.
26. Ribas SG, Ondoa P, Schupbach J, van der Groen G, Fransen K (2003) Performance of a quantitative HIV-1 p24 antigen assay on various HIV-1 subtypes for the follow-up of HIV-1 seropositive individuals. J Virol Methods 113: 29-34.
27. Prado JG, Shintani A, Bofill M, Clotet B, Ruiz L, et al. 2004. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of HIV-1 RNA in patients with chronic HIV infection during structured treatment interruptions. J Clin Microbiol 42: 1620-1625.
28. Bonard D, Rouet F, Toni TA, Minga A, Huet C, et al. (2003) Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Cote d'Ivoire, West Africa. J Acquir Immune Defic Syndr 34: 267-273.
29. Respess RA, Cachafeiro A, Withum D, Fiscus SA, Newman D, et al. (2005) Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to HIV-1 RNA viral load in resource-limited settings. J Clin Microbiol 43: 506-508.
30. Jennings C, Danilovic A, Burgess D, Morack R, Fiscus S, et al. A comparison of two non-RNA-based assays for the quantitation of HIV [abstract]. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 2003 September 14-17; Chicago, Illinois, United States of America. American Society for Microbiology. Available: http://gateway.nlm.nih.gov/robot_pages/ MeetingAbstracts/102266490.html. Accessed 7 September 2006.
31. Simonds RJ, Brown TM, Thea DM, Orloff SL, Steketee RW, et al. (1998) Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study. AIDS 12: 1545-1549.
32. Cunningham CK, Charbonneau TT, Song K, Patterson D, Sullivan T, et al. (1999) Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J 18: 30-35.
33. Young NL, Shaffer N, Chaowanachan T, Chotpitayasunondh T, Vanparapar N, et al. (2000) Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr 24: 401-407.
34. Benjamin DK Jr, Miller WC, Fiscus SA, Benjamin DK, Morse M, et al. (2001) Rational testing of the HIV-exposed infant. Pediatrics 108: E3.
35. Lambert JS, Harris DR, Stiehm ER, Moye J Jr, Fowler MG, et al. (2003) Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr 34: 512-519.
36. World Health Organization (2004) Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach. 2003 revision. Available: http://www.who.int/3by5/publications/documents/ arv_guidelines/en/. Accessed 6 September 2006.
37. Lyamuya E, Bredberg-Raden U, Massawe A, Urassa E, Kawo G, et al. (1996) Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 12: 421-426.
38. Nadal D, Boni J, Kind C, Varinier OE, Steiner F, et al. (1999) Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric HIV-1 infections. J Infect Dis 180: 1089-1095.
39. Sutthent R, Gaudart N, Chokpaibulkit K, Tanliang N, Kanoksinsombath C, et al. (2003) p24 antigen detection assay modified with a booster step for diagnosis and monitoring of HIV-1 infection. J Clin Microbiol 41: 1016-1022.
40. Sherman GG, Stevens G, Stevens W (2004) Affordable diagnosis of HIV infection in infants by p24 antigen detection. Pediatr Infect Dis J 23: 173-176.
41. Zijenah LS, Tobaiwa O, Rusakaniko S, Nathoo KJ, Nhembe M, et al. (2005) Signal-boosted qualitative ultrasensitiev p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years. J Acquir Immune Defic Syndr 39: 391-394.
42. De Baets AJ, Edidi BS, Kasali MJ, Beelaert G, Schrooten W, et al. (2005) Pediatric human immunodeficiency virus screening in an African district hospital. Clin Diagn Lab Immunol 12: 86-92.
43. Knuchel MC, Tomasik Z, Speck RF, Luthy R, Schupbach J (2006) Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings. J Clin Virol 36: 64-67.
44. Li CC, Seidel KD, Coombs RW, Frenkel LM (2005) Detection and quantification of HIV-1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions. J Clin Microbiol 43: 3901-3905.
45. Patton JC, Sherman GG, Coovadia AH, Stevens WS, Meyers TM (2006) Ultrasensitive HIV-1 p24 antigen assay modified for use on dried whole blood spots as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol 13: 152-155.
46. Malmsten A, Shao XW, Aperia K, Corrigan GE, Sandstrom E, et al. (2003) HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol 71: 347-359.
47. Malmsten A, Shao XW, Sjodahl S, Fredriksson EL, Pettersson I, et al. (2005) Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol 76: 291-296.
48. Braun J, Plantier JC, Hellot MF, Tuaillon E, Gueudin M, et al. (2003) A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 17: 331-336.
49. Greengrass VL, Turnbull SP, Hocking J, Dunne AL, Tachedjian G, et al. (2005) Evaluation of a low cost reverse transcription assay for plasma HIV-1 viral load monitoring. Curr HIV Res 3: 183-190.
50. Seyoum E, Wolday D, Girma M, Malmsten A, Meselle T, et al. (2006) Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: Relation to RNA copy number and CD4 T-cell count. J Med Virol 78: 161-168.
51. Sivapalasingam S, Essajee S, Nyambi PN, Itri V, Hanna B, et al. (2005) Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: Implications for resource-limited settings. J Clin Microbiol 43: 3793-3796.
52. Lewin SR, Vesanen M, Kostrikos L, Hurley A, Duran M, et al. (1999) Use of real-time PCR and molecular beacons to detect virus replication in HIV-1 infected individuals on prolonged effective antiretroviral therapy. J Virol 73: 6099-6103.
53. de Baar MP, Timmermans EC, Bakker M, de Rooij E, van Gemen B, et al. (2001) Onetube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG. J Clin Microbiol 39: 1895-1902.
54. de Baar MP, Timmermans EC, Buitelaar M, Westrop M, Dekker JT, et al. (2003) Evaluation of the HIV-1 RNA RetinaTM Rainbow assay on plasma and dried plasma spots: Correlation with the Roche Amplicor HIV-1 Monitor v 1.5 assay. Antivir Ther 8 (Suppl 1): S533.
55. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, et al. (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41: 4531-4536.
56. Ayele W, Pollakis G, Abebe A, Fisseha B, Tegbaru B, et al. (2004) Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia. J Clin Microbiol 42: 1534-1541.
57. Luo W, Yang H, Rathbun K, Pau CP, Ou CY (2005) Detection of HIV-1 DNA in dried blood spots by a duplex real-time PCR assay. J Clin Microbiol 43: 1851-1857.
58. Stevens W, Wiggill T, Horsfield P, Coetzee L, Scott LE (2005) Evaluation of the NucliSens EasyQ assay in HIV-1 infected individuals in South Africa. J Virol Methods 124: 105-110.
59. Yao J, Liu Z, Ko LS, Pan G, Jiang Y (2005) Quantitative detection of HIV-1 RNA using NucliSens EasyQ HIV-1 assay. J Virol Methods 129: 40-46. .
60. Rekhviashvii N, Stevens G, Scott L, Stevens W (2006) Fluorogenic LUX primer for quantitation of HIV-1 by real-time RT-PCR. Mol Biotechnol 32: 101-110.
61. Swanson P, Huang S, Holzmayer V, Bodelle P, Yamaguchi J, et al. (2006) Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. J Virol Methods 134: 237-243.
62. Rouet F, Ekouevi DK, Chaix ML, Burgard N, Inwoley A, et al. (2005) Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of HIV-1 infection in a West African resource-limited setting. J Clin Microbiol 43: 2709-2717.
63. Gueudin M, Simon F (2005) Plasma RNA viral load in HIV-1 group O infection by real-time PCR. Methods Mol Biol 304: 221-228.
64. Gueudin M, Plantier JC, Damond F, Roques P, Mauclere P, et al. (2003) Plasma viral RNA assay in HIV-1 group O infection by real-time PCR. J Virol Methods 113: 43-49.
65. Candotti D, Temple J, Owusu-Ofori S, Allain JP (2004) Multiplex real-time quantitative realtime PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods 118: 39-47.
66. Cassol S, Gill MJ, Pilon R, Cormier M, Voigt RF, et al. (1997) Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J Clin Microbiol 35: 2795-2801.
67. Fiscus SA, Brambilla D, Grosso L, Schock J, Cronin M (1998) Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J Clin Microbiol 36: 258-260.
68. O'Shea S, Mullen J, Corbett K, Chrystie I, Newell ML, et al. (1999) Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 13: 630-631.
69. Biggar RJ, Broadhead R, Janes M, Kumwenda N, Taha TE, et al. (2001) Viral levels in newborn African infants undergoing primary HIV-1 infection. AIDS 15: 1311-1313.
70. Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau AM, et al. (2003) Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol 41: 1888-1893.
71. Mwaba P, Cassol S, Nunn A, Pilon R, Chintu C, et al. (2003) Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients. Lancet 362: 2067-2068.
72. Uttayamakul S, Likanonsakul S, Sunthornkachit R, Kuntiranont K, Luoisirirotchankul S, et al. (2005) Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection. J Virol Methods 128: 128-134.
73. Rollins NC, Dedicoat M, Danaviah S, Page T, Bishop K, et al. (2002) Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet 360: 389.
74. Cassol S, Salas T, Arella M, Neumann P, Schechter MT, et al. (1991) Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction. J Clin Microbiol. 29: 667-671.
75. Cassol SA, Lapointe N, Salas T, Hankins C, Arella M, et al. (1992) Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J Acquir Immune Defic Syndr 5: 113-119.
76. Comeau AM, Harris J, McIntosh K, Weiblen BJ, Hoff R, et al. (1992) Polymerase chain reaction in detecting HIV-1 infection among seropositive infants: Relation to clinical status and age and to results of other assays. J Acquir Immune Defic Syndr 5: 271-278.
77. Cassol S, Butcher A, Kinard S, Spadoro J, Sy T, et al. (1994) Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J Clin Microbiol 32: 2641-2645.
78. Yourno J, Conroy J (1992) A novel polymerase chain reaction method for detection of human immunodeficiency virus in dried blood spots on filter paper. J Clin Microbiol 30: 2887-2892.
79. Comeau AM, Hsu HW, Schwerzler M, Mushinsky G, Walter E, et al. (1993) Identifying human immunodeficiency virus infection at birth: Application of polymerase chain reaction to Guthrie cards. J Pediatr 123: 252-258.
80. Nyambi PN, Fransen K, De Beenhouwer H, Chomba EN, Temmerman M, et al. (1994) Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol 32: 2858-2860.
81. Biggar RJ, Miley W, Miotti P, Taha TE, Butcher A, et al. (1997) Blood collection on filter paper: A practical approach to sample collection for studies of perinatal HIV transmission. J Acquir Immune Defic Syndr 14: 368-373.
82. Panteleeff DD, John G, Nduati R, Mbori-Ngacha D, Richardson B, et al. (1999) Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 37: 350-353.
83. Beck IA, Drennan KD, Melvin AJ, Mohan KM, Herz AM, et al. (2001) Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol 39: 29-33.
84. Fischer A, Lejczak C, Lambert C, Servais J, Makombe N, et al. (2004) Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol 42: 16-20.
85. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS (2005) Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr 38: 615-617.
86. Sriwanthana B, Wetprasit N, Chareonsook S, Janejai N, Chareonsiriwatana W (2003) A study to implement early diagnosis of HIV infection in infants born to infected mothers. Southeast Asian J Trop Med Public Health 34 (Suppl 3): 221-226.
87. Li CC, Beck IA, Seidel KD, Frenkel LM (2004) Persistence of human immunodeficiency virus type 1 subtype B DNA in dried-blood samples on FTA filter paper. J Clin Microbiol 42: 3847-3849.
88. Behets F, Kashamuka M, Pappaioanou M, Green TA, Ryder RW, et al. (1992) Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol 30: 1179-1182.
89. Cassol S, Weniger BG, Babu PG, Salminen MO, Zheng X, et al. (1996) Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: A new surveillance tool for molecular epidemiology. AIDS Res Hum Retroviruses 12: 1435-1441.
90. Lee DH, Li L, Andrus L, Prince AM (2002) Stabilized viral nucleic acids in plasma as an alternative shipping method for NAT. Transfusion 42: 409-413.
91. Dineva MA, Candotti D, Fletcher-Brown F, Allain JP, Lee H (2005) Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 43: 4015-4021.
92. Guttikonda S, Wang W, Suresh M (2004) Molecular zipper assays: A simple homosandwich with the sensitivity of PCR. J Pharm Pharm Sci 7: 7-16.